Navigation Links
Antigen


An antigen is any molecule that is recognized by antibodies. Usually, an antigen is a protein or a polysaccharide, but it can be any type of molecule, even small molecules if coupled to a large carrier (haptens).


There are several kinds of antigens:

  • Immunogen - Any substance that provokes an immune response (provokes immunity) when introduced into the body. An immunogen is always a macromolecule (protein, polysaccharide). Its ability to provoke the immune response depends on its foreignness to the host, molecular size, chemical composition and heterogeneity (e.g. different amino acids in a protein).
  • Tolerogen - An antigen that invokes a specific immune unresponsiveness due to its molecular form . A tolerogen can become an immunogen if its molecular form is changed.
  • Allergen - An allergen is any substance that causes an allergic reaction. It can be eaten, inhaled, injected or comes into contact with skin.

Antigens are presented by a cell to its environment via a histocompatibility molecule. Depending on the antigen presented and the histocompatibility molecule used, several types of immune cells can leap into action.

We can also classify antigens according to where they come from:

  • Exogenous antigens

Exogenous antigens are antigens that have entered the body, e.g., by inhalation, ingestion, or injection. These antigens are taken up by endocytosis or phagocytosis into the antigen presenting cells (APCs), and degraded into fragments. The fragments are then presented on the surface of APCs by class II histocompatibility molecules to T helper cells (CD4+). Those that are specific for them, get activated, so they start to secrete cytokines. The cytokines then activate cytotoxic lymphocytes T (CTL), antibodies secreting lymphocytes B , macrophages and other cells.

  • Endogenous antigens

Endogenous antigens are antigens that have been generated within the cell, as a result of normal cell metabolism, or because of viral or intracellular bacterial infection. The fragments are then presented on the cell surface in the complex with class I histocompatibility molecules. If cytotoxic CD8+ T cells recognize them, they begin to secrete different toxins that cause the lysis or apoptosis of the infected cell. In order to keep the cytotoxic cells from killing cells just for presenting normal proteins, they run through a test cycle (negative control in the thymus) just after their production. Only those CTL that do not react to normal body protein fragments are allowed to enter the bloodstream.


'"/>


(Date:10/28/2014)... of the tragic realities of cancer is that ... toxic and their effectiveness varies unpredictably from patient ... poised to change this reality by rapidly assessing ... an individual,s cancer before chemotherapy begins. , A ... by Assistant Professor Melissa Skala has developed the ...
(Date:10/28/2014)... announced awards to expand the Office of Rare ... Advancing Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical ... scientists at 22 consortia will work with 98 ... investigate new treatments for patients with rare diseases. ... in fiscal 2014 funding from NIH. , Rett ...
(Date:10/28/2014)... be building a hybrid micro-grid which will integrate ... in the region, the hybrid micro-grid will test ... diesel, storage and power-to-gas technologies, and ensure these ... built under the new Renewable Energy Integration Demonstrator- ... located offshore at Semakau Landfill and is expected ...
Breaking Biology News(10 mins):Improving breast cancer chemo by testing patient's tumors in a dish 2Improving breast cancer chemo by testing patient's tumors in a dish 3NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3
... all the genetic sequences in living organisms, has leaned ... the blueprint, unfortunately, has been unintelligible, with no good ... link genomic features to cell function. , A national ... non-profit research center, and Pacific Northwest National Laboratory (PNNL), ...
... Medicine have identified a link between a critical cancer ... be expressed in a number of EBV-associated cancers. Their ... human B cells from the immune system into cancerous ... , Erle S. Robertson, PhD, Associate Professor of Microbiology ...
... target in their fight against a dangerous bacterium that ... implants such as catheters, artificial joints and heart valves. ... epidermidis has, for the first time, been shown to ... that would otherwise kill the bacteria, according to scientists ...
Cached Biology News:Fleshing out the genome 2Defensins neutralize anthrax toxin 2Substance protects resilient staph bacteria 2
Other biology definitionOther Tags